FLAG-sequential regimen followed by bone marrow transplantation for myelodysplastic syndrome or acute leukemia in patients with Fanconi anemia: a Franco-Brazilian study

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Shimamura A, Alter BP. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev. 2010;24:101–22.

    CAS  Article  Google Scholar 

  2. 2.

    Kutler DI. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood. 2003;101:1249–56.

    CAS  Article  Google Scholar 

  3. 3.

    Quentin S, Cuccuini W, Ceccaldi R, Nibourel O, Pondarre C, Pagès M-P, et al. Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions. Blood. 2011;117:e161–70.

    CAS  Article  Google Scholar 

  4. 4.

    Latour RP, de, Porcher R, Dalle J-H, Aljurf M, Korthof ET, Svahn J, et al. Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience. Blood. 2013;122:4279–86.

    Article  Google Scholar 

  5. 5.

    Peffault de Latour R, Soulier J. How I treat MDS and AML in Fanconi anemia. Blood. 2016;127:2971–9.

    CAS  Article  Google Scholar 

  6. 6.

    Ayas M, Saber W, Davies SM, Harris RE, Hale GA, Socie G, et al. Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia. J Clin Oncol. 2013;31:1669–76.

    Article  Google Scholar 

  7. 7.

    Schmid C, Schleuning M, Ledderose G, Tischer J, Kolb H-J. Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol. 2005;23:5675–87.

    Article  Google Scholar 

  8. 8.

    Talbot A, Latour RP de, Raffoux E, Buchbinder N, Vigouroux S, Milpied N et al. Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia. Haematologica 2014: haematol.2013.098954.

  9. 9.

    Mitchell R, Wagner JE, Hirsch B, DeFor TE, Zierhut H, MacMillan ML. Haematopoietic cell transplantation for acute leukaemia and advanced myelodysplastic syndrome in Fanconi anaemia. Br J Haematol. 2014;164:384–95.

    CAS  Article  Google Scholar 

  10. 10.

    Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, et al. Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation. N. Engl J Med. 2017;377:2433–44.

    CAS  Article  Google Scholar 

  11. 11.

    Bonfim C, Ribeiro L, Nichele S, Loth G, Bitencourt M, Koliski A, et al. Haploidentical bone marrow transplantation with post-transplant cyclophosphamide for children and adolescents with Fanconi anemia. Biol Blood Marrow Transplant. 2017;23:310–7.

    Article  Google Scholar 

  12. 12.

    Peffault de Latour R, Chevret S, Jubert C, Sirvent A, Galambrun C, Ruggeri A, et al. Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study. Blood. 2018;132:750–4.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

The authors thank the patients, their families, and the “Association Française de la Maladie de Fanconi” (https://www.fanconi.com/). The authors would like to thank members of the Société Française de Greffe de Moelle et de Thérapie cellulaire (SFGM‐TC), the SFGM‐TC data manager Nicole Raus and all collaborators who contributed to patients recruitment, data registration, and quality control. The authors thank the nurses and physicians who cared for these patients and their families. This study has been conducted in compliance with the Declaration of Helsinki.

Author information

Affiliations

Authors

Corresponding author

Correspondence to P. E. Debureaux.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Debureaux, P.E., Sicre de Fontbrune, F., Bonfim, C. et al. FLAG-sequential regimen followed by bone marrow transplantation for myelodysplastic syndrome or acute leukemia in patients with Fanconi anemia: a Franco-Brazilian study. Bone Marrow Transplant (2020). https://doi.org/10.1038/s41409-020-0994-2

Download citation